New agent for nitric oxide (NO) chemotherapy: Synthesis and properties of DNIC with hydrazinium cation in solid phase and solutions

Add time:08/09/2019    Source:sciencedirect.com

New method for the synthesis of the mononuclear anionic iron dinitrosyl complexes (DNICs) as prospective agents for nitric oxide (NO) chemotherapy of oncological diseases has been developed. Mononuclear anionic DNIC of the composition (N2H5)+[Fe(SR)2(NO)2]- with R = 5-nitropyridinyl (I) has been synthesized by the reaction of aqueous solutions of Na2[Fе(S2O3)2(NO)2] and N2H5[SС5H3N2O2] salts. The latter one was synthesized by the reduction of bis-(5-nitro-pyridin-2-yl) disulfide with hydrazine hydrate in ethanol at T = 25 °C. Physical-chemical properties of the synthesized complex were studied by X-ray, SEM, IR-, EPR, Mössbauer spectroscopy and SQUID magnetometry in combination with DFT quantum-chemical calculation of molecular structure and spectroscopic properties. Complex I was found to generate NO in proton media without additional activation. The cytotoxicity of I to human tumor cells of various geneses, viz. ovarian cancer SKOV3, colon cancer LS174T and non-small cell lung cancer A549 was discovered for the first time.

We also recommend Trading Suppliers and Manufacturers of 3-Methoxy-4-nitropyridine N-oxide (cas 19355-04-5). Pls Click Website Link as below: cas 19355-04-5 suppliers

Prev:Studies on correlations of acid-base properties of substituted pyridine N-oxides in solutions. Part 2: Correlations of the pKa values in non-aqueous media
Next:Lipase catalysed kinetic resolutions of 3-aryl alkanoic acids)